Delivery Order SPE2DB24D9222-SPE2DB24FAZFR

Award Date 8/9/24
Potential Completion Date 8/30/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of YF-VAX 1 DOSE VIALS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,126.98 and an ultimate completion date of October 2, 2024. It is not associated with any set-aside designation. DMS Pharmaceutical Group holds a...
This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $2,226.84 and is structured as a firm fixed-price delivery order, valid through April 11, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract...
This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $6,680.52, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with an ultimate completion date of February 13, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a supply chain management agency within the Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $11,269.80 and a period of performance ending on December 13, 2024. This contract is not...
This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $4,453.68, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed price, and the ultimate completion date is July 16, 2025. DMS Pharmaceutical Group Inc. is an established federal contractor, holding a significant...
This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $2,226.84 and an ultimate completion date of March 6, 2025. DMS Pharmaceutical Group Inc. holds a single-award Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a defense agency. The $5,567.10 firm fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of March 31, 2025 and is not associated with any set-aside designations. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...
This contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA) under the Medical Supply Chain division, a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award has a ceiling value of $1,690.47 and is a firm fixed-price delivery order. The contract has no set-aside designation and is part of a larger indefinite delivery contract (IDC) with a...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a firm fixed-price delivery order contract worth $1,126.98 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of the YF-VAX 1 dose vaccine vials, with a period of performance through October 23, 2024. This delivery order contract is part of a larger, single-award indefinite delivery contract (IDC) the DLA has with DMS...
The federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,034.80 firm fixed-price delivery order is for the supply of YF-VAX 1 dose vials, with a completion date of February 4, 2022. This award is part of a larger indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This...
  • SPE2DB24D9222
    Indefinite Delivery Contract
  • SPE2DB24D9222-SPE2DB24FAZFR
    Delivery Order

The federal contract award is for the delivery of YF-VAX 1 dose vials to the Defense Logistics Agency (DLA), a defense agency. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $1,126.98 and an ultimate completion date of August 30, 2024. DMS Pharmaceutical Group holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This single-award IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract has no set-aside designation.

Generated 11/8/24, 9:23 AM